ArticleACS pharmacology & translational science2025
Ponatinib Averts αCD40 Antibody Mediated Toxicity by Lowering MAPK38 Expression and Shows Proimmunogenic Effects in a Murine Tumor Model.
Vidit Gaur et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.